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BACKGROUND:While studies have been published in the
last 30 years that examine the effect of charge display
during physician decision-making, no analysis or synthe-
sis of these studies has been conducted.
OBJECTIVE:We aimed to determine the type and quality
of charge display studies that have been published; to
synthe-size this information in the form of a literature
review.
METHODS: English-language articles published between
1982 and 2013 were identified using MEDLINE, Web of
Knowledge, ABI-Inform, and Academic Search Premier.
Article titles, abstracts, and text were reviewed for rele-
vancy by two authors. Data were then extracted and sub-
sequently synthesized and analyzed.
RESULTS: Seventeen articles were identified that fell into
two topic categories: the effect of charge display on radiology
and laboratory test ordering versus on medication choice.
Seven articles were randomized controlled trials, eight were
pre-intervention vs. post-intervention studies, and two in-
terventions had a concurrent control and intervention
groups, but were not randomized. Twelve studies were con-
ducted in a clinical environment, whereas five were survey
studies. Of the nine clinically based interventions that ex-
amined test ordering, seven had statistically significant re-
ductions in cost and/or the number of tests ordered. Two of
the three clinical studies looking atmedication expenditures
found significant reductions in cost. In the survey studies,
physicians consistently chose fewer tests or lower cost op-
tions in the theoretical scenarios presented.
CONCLUSIONS: In the majority of studies, charge infor-
mation changed ordering and prescribing behavior.
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INTRODUCTION
The United States consistently outspends other industrialized
countries on health care, but with lower health care outcomes.1
Healthcare costs in the United States were 17.9 % of the gross
domestic product (GDP) in 2012 according to the World
Bank—the highest GPD percentage spent on health care in
the world.2 At the same time, US life expectancy lags behind
other developed nations.1 One contributing factor to rising
health care costs is that physicians rarely know the charges
of the services, tests, and procedures they order or perform.3,4
This disconnect between the trend in rising health care costs
and physician lack of knowledge about the financial impact of
their management decisions leads to an obvious concept for an
intervention: provide a currency amount for the intervention in
question for physicians when they are deciding what tests to
order or what medications to prescribe. Yet, this has hardly
become commonplace practice in the United States.5–8
There have, however, been a number of studies that have
tested the hypothesis that price information reduces ordering
and costs, but there has been no synthesis of these studies. This
information could be informative to policymakers, patient
advocates, insurance companies, hospitals, and medical
groups, who are all trying to find ways to reduce overuse
and control costs.
The purpose of this systematic review was to determine the
type of charge display studies that have been published, the
quality of these studies, and their findings. We wanted to
synthesize this information in the form of a literature review.
We set out to identify studies where the intervention provided
medical practitioners with a currency amount that reflected the
charge of what they were ordering in real time, and then
analyzed the differences in ordering behavior. We chose to
narrow in on reviewing interventions specifically looking at
real time charge display and its effect on physician decisions,
rather than the broader topic of performance feedback, which
was thoroughly explored in a recent Cochrane Review by
Ivers et al.,9 as well as more general literature review by
Axt-Adam et al. in the early 1990s.10
We would like to comment on terminology at this juncture.
The terms Bprice,^ Bcost,^ Bcharge,^ and Bfee^ are often used
interchangeably in this literature, even though there are nu-
anced differences to these terms. All interventions we exam-
ined included a currency value that physicians could incorpo-
rate into their management decisions. The source of this cur-
rency value was not consistently disclosed, as we will discuss
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later. In every health system, there are many layers to how the
costs are generated and how services are paid for, thereby
generating prices, fees, charges, etc. This systematic review
did not attempt to reconcile these differences, but to assess
various interventions with aforementioned intention. Through-
out this review, we refer to currency amounts displayed using
the same term as the authors of the paper did in their description.
For our discussion, we chose the term Bcharge display^ to
discuss the concept as it pertains to physician decision-making.
METHODS
Design, Data Sources, and Search Criteria.We performed a
systematic review of English-language articles published be-
tween 1982 and October 2013 using MEDLINE, Web of
Knowledge, ABI-Inform, and Academic Search Premier, the
details of which are outlined in Figure 1. The search strategy
was developed by two of the authors (C.G. and H.A.B.E.).
Search terms included medical descriptors, financial terms,
behavior descriptors, andmedical action as detailed in Table 1.
We also manually searched reference lists in relevant articles.
Study Selection. We included articles that studied the effect of
charge display interventions (including educational
interventions) on the use of services, cost of care, or changes
in physician decisions. The intervention had to provide charge
data in Breal time^—meaning that a currency value was
displaced to the provider at the time of ordering. We included
studies that had both a concurrent comparison group and those
that used a pre-intervention vs. post-intervention design with no
concurrent comparison group. We only included studies that
provided quantitative results. We did not include studies where
the outcome was change in attitudes, but did include studies
where the outcome was change in case-based decisions. One
reviewer (C.G.) assessed titles for relevance. Two reviewers
(C.G. and S.R.R.) assessed selected abstracts for relevance
and full articles for inclusion. When the reviewers disagreed,
an additional reviewer (T.F.B.) resolved the discrepancy.
Data Extraction. Two authors (C.G. and G.H.) extracted the
following data from selected articles: study design, setting,
type of intervention, type of participants, number of
participants, bias considerations, type of outcome measures,
and results. These data are organized in Table 2.
Data Synthesis and Analysis. We grouped studies into two
categories: 1) laboratory and radiology test ordering, 2)
medication choices. For each study, we focused on three
types of outcomes: 1) use of specific medical services or
treatments, 2) cost of care, and 3) physician decisions. We
were unable to perform a meta-analysis, because the studies
were too heterogeneous.
RESULTS
Of the 4,513 articles identified through electronic search
(search terms are outlined in Table 1), 71 articles were selected
after title review, and from those articles, eight articles were
selected by two reviewers after full article review. We identi-
fied nine more articles through reference review, for a total of
17 articles (Fig. 1).
Twelve studies were conducted in a clinical environment11–22
while five were survey or simulation studies (i.e., studies that
asked physicians how theymight behave in a clinical setting).23–27
Of the seventeen studies, seven were randomized controlled
trials,11,12,14,19,23,24,26 eight were pre-intervention vs. post-
intervention studies,15,16,18,20–22,25,27 and two had a concurrent
control and intervention groups, but were not randomized.13,17
Eleven studies examined physician ordering of laboratory or
radiology testing,11–19,23,24 while six looked at medication
choice.20–22,25–27 The details of the study design, study size,
bias considerations, and follow-up period for the included
studies are summarized in Table 2.
Interventions in a Clinical Setting
Effects on Radiology and Laboratory Test Ordering. There
were a total of nine papers in this category: four randomized
controlled trials,11,12,14,19 two non-randomized controlled tri-
al,13,17 and three pre-intervention vs. post-intervention stud-
ies15,16,18 that looked at test ordering. Four interventions were
conducted in inpatient wards11–14 two were conducted in
emergency department,15,17 two were in intensive care
units,16,18 and one was in an internal medicine outpatient
clinic.19 Six were conducted in the United States11,12,14–16,19;
studies were also conducted in South Africa,13 Sweden,17 and
France.18 Two studies came from the pediatric literature.15,16
The clinical interventions themselves included four electron-
ic medical record (EMR)11,12,14,19 and five paper-based inter-
ventions.13,15–18 The EMR interventions very similar: the win-
dow for a patient’s orders included the charge amounts.12,14,19
Bates et al. had a Bcash register^ component that totaled the
charges.11 Among the paper-based methods, Hampers et al. and
Seguin et al. placed charges next to the items ordered on paper
order forms in a pediatric ED15 and in a French intensive care
unit,18 respectively. Sachedeva et al. placed itemized charges
from the prior day’s test charges every morning where orders
were subsequently placed.16 Ellemdin et al. gave physicians a
pocket-sized brochure with laboratory costs; physicians then
had to write that amount on the order requisition.13 Schilling
distributed price lists via email to physicians and then had this
list displayed at the physicians’ workstations.17
Only four studies reported the sources of displayed charges.
Two studies stated that the currency amounts reflected what
the clinic or hospital charged to the insurer or to the patient if
the patient did not have insurance,11,19 and two other studies
used the Medicare allowable fee for the test.12,14
Three studies were designed with a quality metric in place.
Hampers et al.’s design included follow-up phone calls to see
if the patient had been medically re-evaluated and to assess
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satisfaction with care. Differences in control vs. intervention
groups on both accounts were not statically significant.15
Sachdeva et al. collected data on occurrences of pediatric
ICU-related complications during the control and intervention
periods to measure quality of care. Length of stay in the ICU
and mortality between the two groups were not statistically
significant.16 Tierney et al. reviewed patients’ computer re-
cords for 26 weeks following the intervention period to com-
pare rates of hospitalization, emergency room visits, and
outpatient visits. No significant differences were found.19
The other six studies did not report a quality metric.
Of the nine clinically based interventions that exam-
ined test ordering, seven had statistically significant
reductions in cost and/or the number of tests ordered.
These results are fully detailed in Table 2. Feldman
et al. reported decreases in number of tests ordered in
both the intervention and control arms compared to pre-
intervention rates; still, the difference in decreases in the
Figure 1. Review process.
Table 1. Search Terms
Medical descriptors Economic terms Behavior descriptors Medical actions
Doctor
Physician
Medic*
Hospital
Lab*
Radiology
Imaging
Pric*
Fee*
Charge*
Budget
Cost
Deci*
Influen*
Bias
Persua*
Convince
Habit
Appropriate*
Inappropriate*
Aware*
Transparenc*
Treat*
Order*
Stud*
Investigat*
Manag*
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Table 2. Summary of Evidence
Article citation Study details Bias considerations Intervention Results
Articles on Lab/Radiology Ordering
Bates, D. et al. Does
the Computerized
Display of Charges
Affect Inpatient Ancillary
Test Utilization? Arch
Intern Med. 1997;
157: 2501–2508
- Randomized
Controlled
design
- Lab test subjects:
3,536 vs. 3,554
inpatient orders;
radiology: 8,728
vs. 8,653 inpatient
orders
- Randomization
performed using
internal identification
number not available
to providers
- Labs sent directly
to lab via envelope
were not captured.
Only 53 % of lab
tests had an associated
computer order. 74 %
of radiology testing
had a computer order.
The cost for each test
ordered was displayed
by the specific test,
as well as the total for
the ordering session in
a Bcash register^
window below the
tests list.
4.5 % decrease in clinical
laboratory tests ordered;
total charges were 4.2 %
lower. Radiology ordering
was reported as practically
identical in control and
experimental periods.
Cost Reduction: Not
statistically significant
Decrease in number of tests
ordered not statistically
significant
Cummings, K. M. et al.
The Effects of Price
Information on Physicians’
Test-Ordering Behavior.
Medical Care. 1982; 20
(3): 293–301.
- Randomized
Controlled design
- Survey study of
36 family medicine
residents and 23
faculty in US
- No description of
randomization process
- 59 of 67 subjects
contacted
participated in the study
(88 % response rate)
Participants reviewed
four cases in which
certain diagnoses were
intended, and then
asked to order tests.
One group used a test
order forms with
prices, the other
without.
The price-information group
ordered 30.8 % fewer tests
per patient than did the
control group.
Cost Reduction: Statistically
significant
Decrease in number of tests
ordered not consistently
statistically significant
Durand, DJ et al.
Provider Cost Transparency
Alone Has No Impact
on Inpatient Imaging
Utilizations. J Am
Coll Radiol 2013;
10: 108–113.
- Randomized
Controlled design
- 5 vs. 5 radiology
tests randomized
to display vs.
control
- Randomization was
performed using
web-based software
The difference in ordering
of radiology tests
randomized to display vs.
blind ordering over 6
months, compared to
similar 6-month
baseline test-ordering data.
Change in utilization was
not significant
between the two groups.
Ellemdin, S et al.
Providing Clinicians
with Information
on Laboratory Test
Costs Leads to Reduction
in Hospital Expenditure.
S Afr Med J. 2011; 201:
746–748.
- Non-Randomized
Controlled design
- 463 vs. 434
Inpatient orders on
wards of South
African hospital
- Control and
intervention groups
were matched in
terms of experience
- 100 % compliance
with intervention
Laboratory test costs were
provided to clinicians as
a pocket-sized brochure.
They were asked to write
in the cost of every test
ordered on the laboratory
test request form.
27 % reduction in mean cost
per patient admitted and 36 %
reduction in mean cost
per day of entire intervention group.
Cost Reduction: Statistically
significant
Change in number of tests
ordered not reported
Feldman, L et al. Impact
of Providing Fee Data on
Laboratory Test Ordering.
JAMA Intern Med. 2013;
173(10): 903–908
- Randomized
Controlled design
- 61 lab tests
randomized to
display vs. blind
- No description of
randomization
process
- Providers were unaware
that displayed feeswere
part of study unless
research team was
specifically questioned
The difference in ordering
of 61 lab tests randomized
to display vs. blind
ordering over 6 months,
compared to similar
6-month baseline
test-ordering data.
9.1 % decrease of number
of tests ordered from baseline
period in active arm; control
arm saw 5.1 % increase. Total
fees for laboratory testing dropped
10.1 % in active arm.
Cost Reduction: statistically
significant
Decrease in number of tests
ordered: statistically significant
Hampers, L.C. et al. The
Effect of Price Information
on Test-ordering Behavior
and Patient Outcomes in a
Pediatric Emergency
Department. Pediatrics.
1999; 103: 877–882.
- Pre-Intervention,
Post-Intervention
design
- 2,467 vs. 2,414
orders in Pediatric
ER in US
- Demographic
differences in control
and intervention
periods are not
statistically
significant.
- Control period and
intervention period
were seasonally
different
During the intervention
period, emergency room
physicians used test order
forms that listed the
standard hospital charge
for each test.
Charges for tests in the
intervention period were
27 % less than charges
in the control period,
without compromising
quality of care, as determined
by a follow phone call.
Cost Reduction: Statistically
significant
Decrease in number of tests
ordered statistically
significant
Rudy, D. W. et al.
A Pilot Study Assessing
the Influence of Charge
Data and Group Process
on Diagnostic Test
Ordering by Residents.
Acad Med. 2001;
76: 635–637.
- Randomized
Controlled design
- Survey of American
23 IM residents
- No description of
randomization
process
or participation rate
At a resident workshop,
participants were given a
hypothetical case and split
into three groups and
ordered lab tests: (A)
given charge data before
ordering, (B) given
charge data after ordering,
and (C) not given charge
data at all.
Residents who had charge
data access spent considerably
less ($1,297 vs. $2,205) but
had lower appropriateness scores.
Cost Reduction: Statistically
significant
Change in number of tests
ordered not reported
(continued on next page)
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Table 2. (continued)
Article citation Study details Bias considerations Intervention Results
Sachdeva, R. C. et al.
Effects of Availability
of Patient-related
Charges on Practice
Patterns and Cost
Containment in the
Pediatric Intensive
Care Unit. Crit Care
Med. 1996; 24:
501–506.
- Pre-Intervention,
Post-Intervention
design
- 598 patients in
Pediatric ICU inUS
- Practitioners were
aware of intervention,
but exact nature of
studywasnotdisclosed
to minimize bias
- Control period and
intervention period
were seasonally
different
Daily patient-related
itemized charges for
laboratory and radiology
tests that had been ordered
in the previous 24-h time
period were displayed in
the patient’s chart.
Lab and pharmacy charges
decreased. The study
adjusted for severity of
illness and intensity of
medical and nursing
interventions.
Cost Reduction: Statistically
significant
Change in number of tests
ordered not reported
Schiling, U. M. Cutting Costs:
the Impact
of Price Lists on the
Cost Development
at the Emergency
Department. Eur J
Emerg Med.
2010; 17: 337–339.
- Non-randomized
Controlled design
- 6,131 orders in
Swedish ER
- Two different
emergency roomorders
were compared
(Orthopedic vs.
Medical)
- Physicians were not
specifically made
aware of the study
Price lists of the 91 most
common lab tests and 39
most common radiological
tests were distributed to
Medicine physicians via
e-mail and were displayed
at the medical working
stations. Orthopedic ER
served as control.
In the experimental group,
lab analysis costs decreased
by 21.4 % (vs. decrease of 9
%) and radiology costs by
20.59 % (vs. increase of 5.4
%). The total number of
radiological investigations
decreased by 4.6 %
(control) vs. 6.8 %
(experimental)
Cost Reduction: Statistically
significant
Decrease in number of tests
ordered only reported for
radiology and was not
statistically significant
Seguin, P. et al.
Effects of Price
Information on
Test Ordering in an
Intensive Care Unit.
Intensive Care Med.
2002; 28: 332–335.
- Pre-Intervention,
Post-Intervention
design
- Orders for 287
patients French
ICU
- Control and
interventional
periods were
seasonally similar
- Data collected by
physicians who did
not practice during
the study duration
- Medical staff was
not notified that a
study was in process
Prices for the seven
most frequently ordered
tests were included on
the lab test ordering
form during the
intervention period.
The total cost reduction was
significant, but significance
was not achieved for
all individual tests.
Cost Reduction: Statistically
significant
Decrease in number of tests
ordered not consistently
statistically significant
Tierney, W. M. et al.
The Effect on Test
Ordering of Informing
Physicians of the
Charges for
Outpatient Diagnostic
Tests. N Engl J Med.
1990; 322: 1499–1504
- Randomized
Controlled design
- Outpatient clinic
orders of 74
physicians in US
- Patient sessions were
randomized using
computer software
- Because of attrition
and completion of
training, ultimately 74
of the 121 physicians
enrolled fully
participated and were
included in analysis.
A window with itemized
charges was displayed
while ordering tests and
medications for
physicians in the
intervention group.
Patient testing charges were
12.9 % lower per visit for
the intervention group.
Residents ordered 15.3 %
fewer tests, resulting in a
13.4 % reduction in
charges. Faculty members
ordered 7.9 % fewer tests,
resulting in an 11.2 %
reduction in charges.
Cost Reduction: Statistically
significant
Decrease in number of tests
ordered statistically
significant
Articles on Medication Choice
Hart, J. et al. Do Drug
Costs Hart,
J. et al. Do Drug Costs
Affect Physician
Prescription Decisions?
J Intern Med. 1997;
241: 415–420.
- Pre-Intervention,
Post-Intervention
design
- Survey study of
60 Israeli
hospitalists and
family physicians
- Participants were
not made aware
of the purpose of
the study
- Participation and
attrition rates not
reported
Questionnaire describing
patients with severe
and mild urinary tract
infection administered
to hospitalist and family
physicians, first without
medication price, then
2months later with prices.
Hospitalists’ choice of
antibiotics was significantly
different and favored the less
expensive medication when
showed price. Family physicians
chose
the less expensive antibiotic
regardless of price display.
Cost reduction – statistical
significance not reported
Medication choice – differences
statistically significant
Horrow, J. C. et al. Price
Stickers
Do Not Alter Drug Usage.
Can J Anaesth. 1994; 41
(11): 1047–1052.
- Pre-Intervention,
Post-Intervention
design
- 56 faculty, resident
andnurse anesthetists
in American OR
- Participants were not
made aware of the
purpose of the study
Supermarket-style price
stickers were placed
on units of selected
pharmaceuticals.
No major differences in the
number of general
anesthetics per week.
Cost reduction – not statistically
significant
Medication choice – usage of
2/11 anesthetics measured were
statistically significantly different.
(continued on next page)
839Goetz et al.: The Effect of Charge Display on CostJGIM
intervention armwere statically significant and resulted in 10%
decrease in fees.14 Tierney et al. found that there were 14.9 %
fewer tests ordered and that testing charges were 12.9 % lower
per visit during the intervention period.19 Ellemdin et al. found
a 27 % reduction in mean cost per admitted patient.13 Hampers
et al. noted a 27 % decrease in charges during the intervention
period compared with the control period.15
Effects on Medication Choice. Interestingly, all three
clinically based interventions looking at medication choice came
from the anesthesiology literature.20–22 All three studies were pre-
intervention vs. post-intervention designs. Two interventions in-
volved supermarket-style price stickers on medications20,21; one
intervention used lists of drug costs.22 One study focused on
muscle relaxants alone,21 whereas two included a broader spec-
trum of medications used in the operating room setting.20,22 Two
interventions included an educational component.20,21
Two of three studies found a significant reduction in total
medication expenditures; one study did not. Lin et al. reported
a shift in muscle relaxant choice towards the less costly option
that resulted in a total expenditure decrease of 12.5 %.21
McNitt reported that the average savings after the intervention
was $32/case.22 Both Lin et al. and McNitt et al. reported that
PACU and SICU admissions, as proxies for quality of care,
were not increased due to medication choice.21,22
Surveys and Simulation Studies
Of the five studies that looked at physician decisions in sur-
veys or simulated settings, two looked at test ordering and
three looked at medication ordering.
Effects on Radiology and Laboratory Test Ordering.
Cummings et al. and Rudy et al. presented resident physicians
with clinical scenarios and randomized surveyees to have charge
information included in the portion of the survey in which the
workup for the clinical scenariowas assessed. Both studies noted
a decrease in ordering when charge information was presented.
Cummings et al. found that the cost of tests ordered for each
hypothetical patient was 31.1 % lower when price information
was provided.23 The design of this study did include a minimum
work-up for each scenario required to preserve quality of care.
Both intervention and control groups met that standard.23
Rudy et al. found that residents with access to charge data
spent less on tests ($1,297 versus $2,205), but also had lower
Bappropriateness^ scores, meaning that the quality of the care
was impacted by the modified test ordering.24
Table 2. (continued)
Article citation Study details Bias considerations Intervention Results
Hux, J. E., Naylor, C. D.
Drug Prices and Third
Party Payment: Do They
Influence Medication
Selection? Pharmaco
Economics. 1994; 5
(4): 343–350.
- Randomized
Controlled design
- Mailed survey
collected from
686 Canadian
PCPs
- Questionnaires were
randomized at mailing
- 71 % response rate
- No significant
differences in demo
graphics of participants
Questionnaire describing
aCOPDpatient randomized
to four different scenarios:
(A) full insurance coverage
and prices of drugs listed,
(B) full insurance coverage
and prices not listed, (C)
prices listed but no insur
ance coverage, (D) neither
prices nor coverage.
When prices were omitted, 38 %
of physicians prescribed the
expensive option, vs. 18 % when
coverage and prices were disclosed.
If it was disclosed that patient had
no drug coverage benefit, 8 %
prescribed expensive antibiotic.
Cost reduction – n/a
Medication choice – statistically
significantly different
Lin, Y-C., Miller, S.R.
The Impact of Price
Labeling of Muscle
Relaxants on Cost
Consciousness among
Anesthesiologists. J Clin
Anesth. 1998; 10:
401–403.
- Pre-Intervention,
Post-Intervention
design
- 20,389 vs. 20,538
cases in
American OR
- Intervention and
Control periods
were seasonally
the same
- Participants were
informed of the
purpose of the study
Subjects underwent an
educational session
about less expensive
muscle relaxants. The
price labels were placed
on vial caps of all muscle
relaxants for 1 year.
Expenditures for the less costly
pancuronium increased while
expenditures for vecuronium
and atracurium decreased.
Total expenditure on muscle
relaxants decreased 12.5 %,
saving $47,311.
Cost reduction – statistically
significant
Medication choice – not reported
McNitt, J. D. et al.
Long-Term Pharmaceutical
Cost Reduction Using
a Data Management
System. Anesth Analg.
1998: 87: 837–842.
- Pre-Intervention,
Post-Intervention
design
- 4,530 vs. 10,600
anesthesia records
from American OR
- Participants were
informed of the
purpose of the study
Cost lists were placed in
each operating room, the
anesthesia satellite
pharmacy, and the
anesthesia lounge.
Providers were encouraged
to use less costly drugs.
Every 2–3 months, the
patterns of use andcostwere
presented to the department.
Costs decreased $30,000 per month
and $32 dollars per case. Quality
indicators did not change.
Cost reduction – reports percent
of change but not percentage
Medication choice – differences
statistically significant
Salman, H. et al. The
Effect of Drug Cost
on Hypertension
Treatment Decision.
Public Health.
1999; 133: 243–246.
- Pre-Intervention,
Post-Intervention
design
- Survey study of
60 Israeli hospitalist
and family
physicians
- Participants were
not made aware of
the purpose of
the study
- Participation and
attrition rates not
reported
Physicians were given two
hypothetical cases about the
treatment of hypertensive
patients. The first time,
prices were not displayed
on the questionnaire. Two
months later, the same
scenario was presented,
but with cost of medication
displayed.
The second questionnaire showed
60 % of the family physicians
and 87 % of the hospital
physicians opted to prescribe the
less expensive drug combination.
Cost reduction – n/a
Medication choice – differences
were statistically significant
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Effects on Medication Choice. The three survey studies that
examined medication choice surveyed non-US physicians
about management of urinary tract infections,25 chronic ob-
structive pulmonary disease,26 and hypertension.27 Hux et al.
surveyed primary care physicians in Canada in which partic-
ipants were randomized to receive information on drug prices
and/or patient insurance coverage, or no information. Each
surveyee was provided with a clinical scenario and asked
about his/her choice of medication and management.26 Hart
et al. and Salman et al. surveyed physicians in Israel with
scenarios involving urinary tract infections and hypertensive
patients, respectively.25,27 In both studies, participants re-
ceived an initial survey that did not include price information.
Two months later, participants received the same survey with
price information. The differences in medication choice were
compared.
Hux et al. found that the percentage of physicians prescrib-
ing the expensive antibiotic option dropped from 38 to 18 %
when insurance coverage and prices were disclosed.26 Hart
et al. and Salman et al. both reported statistically significant
differences in medication choices after prices were disclosed.
Physicians surveyed prescribed the less expensive antibiotic
56 % initially, compared to 83 % when price was disclosed in
Hart et al..25 In Salman et al., cost disclosure prompted 57% of
family practice physicians and 87% of hospitalists surveyed to
choose the less expensive medication, both of which conferred
statistically significant p values.27
CONCLUSIONS
In this systematic review of charge transparency interventions,
we found that having real-time access to charges changed
ordering and prescribing behavior in the majority of studies.
Of the clinically based interventions looking at laboratory and
radiology ordering, seven of the nine studies reported statisti-
cally significant cost reduction when charges were displayed.
Interestingly, of the six studies that reported differences in the
number of tests ordered, only three reported a statistically
significant decrease in the number of tests ordered. This may
reflect that awareness of cost may lead a practitioner to order a
less expensive test rather than fewer tests.
The clinically based interventions that focused on medica-
tion choice again trended towards a decrease in cost when
currency amounts were displayed on medication—two of the
three reported statistically significant reduction. All three sur-
vey studies also showed a trend towards choosing less expen-
sive medication options when price was displayed, though
these were hypothetical situations.
It is worth noting that the two studies with non-significant
findings of the clinically based studies examined ordering
patterns for radiology tests. Bates et al. reported a decrease
in laboratory ordering, though not of statistical significance,
and no difference in the ordering of radiology when price was
displayed.11 Durand et al. only focused on radiology ordering,
randomizing the various modalities that could be ordered, and
found no difference.12
There was considerable heterogeneity in the clinical setting,
patient population (pediatric vs. adult), health care system (in-
ternational vs. US), study design, and outcomes measured. The
majority of interventions took place in the inpatient setting, with
two studies based in emergency medicine. Tierney et al. stands
alone as the one outpatient clinically based study included in
this analysis.19 All of these studies were conducted at a single
site. Even among the clinically based randomized controlled
interventions, there were differences in design: Feldman et al.
and Durand et al. randomized the tests themselves, whereas
Bates et al. and Tierney et al. randomized the patient encounters.
DISCUSSION
To our knowledge, no other literature review has specifically
looked at real-time charge display and its impact on physician
practice patterns. While this synthesis of data from the litera-
ture points toward the potential of cost-savings when prices
are displayed, it is unclear whether universal availability of a
currency amount will have enough impact to significantly
bend the cost curve on a system-wide or national level. Indeed,
as several recent articles have pointed out,4,6 finding exact
charges of tests and medication can be very challenging—the
resources necessary to find and integrate this information in
real time, may outweigh the savings gained.
Another unanswered question is whether changes in prac-
tice from charge display affect quality of care. While some
studies did incorporate a qualitymetric, the majority did not. A
primary concern of physicians modifying practice patterns is
that the quality of patient care will be compromised. Clearly,
this is an area for further study.
Bias is another consideration in synthesizing these data. As
the intervention in question is one of transparency, blinding
subjects and assessors to the intervention is not possible.
Several papers disclose that subjects were not aware that they
were being studied; others specifically included an educational
component as part of the intervention. The danger of perfor-
mance bias and detection bias is inherent to these interven-
tions. Reporting bias is another consideration, though we are
reassured that studies with both significant and statically in-
significant results have been included in the literature. Another
limitation to acknowledge is that our review may have not
have captured all articles on this subject. Indeed, only articles
from the medical literature were ultimately included. We used
search terms and search engines with the hopes of finding
studies from policy, economics, and lay literature, but no
additional interventions were identified.
Were charge data to be more broadly adopted, a significant
issue to consider is what charge the ordering practitioner
should use. There is often great discrepancy in the currency
amount among what a hospital or clinic charges, what an
insurance company reimburses, what a patient pays, and the
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cost to the larger medical system. These studies do not address
which of these costs a clinician should consider when making
ordering decisions. Indeed, the source of the charge presented
was not consistently reported in these studies.
Finally, the decreases in costs reported in these studies focus
primarily on the cost-savings to the hospital or clinical pro-
vider. What remains to be seen is whether charge transparency
decreases medical expense to the patient. Potentially, the doc-
tor–patient relationship could benefit from increased transpar-
ency about medical costs, though this has yet to be established.
There are growing calls for physicians to factor the financial
consequences into their medical decisions.28–30 Charge data
offers additional information for physicians to make the most
educated decisions for a patient’s care.
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